Portfolio companies
Go to website ImVisioN Therapeutics ImVisioN Therapeutics Inc. develops therapies to treat allergic diseases
www.imvision
Go to website MacroGenics MacroGenics Inc. develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases
www.macrogenics
Go to website Mentice Mentice AB supplies virtual reality based applications for medicine
www.mentice
Palyon Logo Palyon Corporation develops implantable and programmable pain pumps
Go to website Sunesis

Sunesis Pharmaceuticals, Inc. (SNSS) develops small molecule therapeutics for oncology
www.sunesis

Telormedix SA develops immuno-selective drugs for the treatment of cancer and other diseases
www.telormedix
Go to website The Genetics Company The Genetics Company Inc. develops diagnostics for Alzheimer’s disease
www.the-genetics
 
Exited companies
Go to website Ganymed Pharmaceuticals Ganymed Pharmaceuticals AG develops monoclonal antibodies for tumor specific targets. The company was acquired by ATS in August 2008.
www.ganymed
Go to website Agensys Agensys, Inc. develops immunotherapeutics to treat cancer. Astellas Pharma Inc. acquired the company in November 2007 for USD 537 million.
www.agensys
Go to website Webwasher Webwasher AG manages and secures networks. The company was acquired in April 2004 by CyberGuard Corp. and later CyberGuard was acquired by Secure Computing Corp.
www.webwasher
Go to website Xelector Xelector Plc is a leader in comparison services in the UK
www.xelector